Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease

CONCLUSIONS: In a broad range of patients with CKD, empagliflozin resulted in a sustained reduction in a bioimpedance-derived estimate of fluid overload, with no statistically significant effect on fat …